The Navy wants to buy the first Trump-class battleship in next year’s budget submission, a schedule that would allow the ...

Cancer immunology is advancing rapidly as researchers seek to unravel the complex, dynamic relationships between tumor cells, immune populations, and the ...

If you happen to keep up with Ford’s F-150, then you might have already been aware of complaints that have been circulating ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...

A recent study has demonstrated the power of metabolic engineering in enhancing the antitumor activity of chimeric antigen ...

First study of agenT-797, botensilimab (BOT) and balstilimab (BAL) in gastroesophageal cancer shows disease control rate (DCR) in 77% of patients ...

Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies ...

Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...